Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Gilles Forte"'
Autor:
Kathleen Anne Holloway, Verica Ivanovska, Solaiappan Manikandan, Mathaiyan Jayanthi, Anbarasan Mohan, Gilles Forte, David Henry
Publikováno v:
PLoS ONE, Vol 15, Iss 2, p e0228201 (2020)
BackgroundPoor quality use of medicines (QUM) has adverse outcomes. Governments' implementation of essential medicines (EM) policies is often suboptimal and there is limited information on which policies are most effective.MethodsWe analysed data on
Externí odkaz:
https://doaj.org/article/aa2aa9ca56e34b18a3125bbedffe2761
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 10, Iss 1 (2017)
Background Barriers to expanding access to medicines include weak pharmaceutical sector governance, lack of transparency and accountability, inadequate attention to social services on the political agenda, and financing challenges. Multi-stakeholder
Externí odkaz:
https://doaj.org/article/06bd82708afa450ebf7b443a7cc5326a
Publikováno v:
The Lancet Global Health, Vol 5, Iss S1, p S6 (2017)
Background: Access to affordable quality essential medicines is crucial if universal health coverage and the Sustainable Development Goals are to be achieved. Multistakeholder initiatives might help to overcome barriers to access such as weak pharmac
Externí odkaz:
https://doaj.org/article/c45fc8e8109544e991f53102ddf2114d
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 8, Iss sup1 (2015)
Externí odkaz:
https://doaj.org/article/3a12e2a291524d6389b4b4a31768674e
Publikováno v:
Bulletin of the World Health Organization, Vol 87, Iss 3, Pp 231-237
OBJECTIVE: To document the inclusion of key medicines for children in national essential medicines lists (EMLs) and standard treatment guidelines, and to assess the availability and cost of these medicines in 14 countries in central Africa. METHODS:
Externí odkaz:
https://doaj.org/article/09035b6534fb4cddbd5e29879f917350
Autor:
Nicola Magrini, Jane Robertson, Gilles Forte, Bernadette Cappello, Lorenzo P Moja, Kees de Joncheere, Marie-Paule Kieny
Publikováno v:
Bulletin of the World Health Organization, Vol 93, Iss 4, Pp 283-284
Externí odkaz:
https://doaj.org/article/833e3ad9ccbb4f1f92bd4c10fd4ae77c
Publikováno v:
International Journal of Health Services. 51:404-411
Little is known on current practices and challenges associated with the legal trade of medicines controlled under international conventions in low-income countries. This qualitative survey involved semi-structured interviews of stakeholders engaged i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b364caefdb7c48f51a5321bde3f1ec57
https://doi.org/10.1177/0020731420906748
https://doi.org/10.1177/0020731420906748
Autor:
Verica Ivanovska, Kathleen Holloway, David Henry, Gilles Forte, Solaiappan Manikandan, Anbarasan Mohan, Mathaiyan Jayanthi
Publikováno v:
PLoS ONE, Vol 15, Iss 2, p e0228201 (2020)
PLoS ONE
PLoS ONE
BackgroundPoor quality use of medicines (QUM) has adverse outcomes. Governments' implementation of essential medicines (EM) policies is often suboptimal and there is limited information on which policies are most effective.MethodsWe analysed data on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d1bc5ba974b7c1ee1158f12ebac14a7
https://doaj.org/article/aa2aa9ca56e34b18a3125bbedffe2761
https://doaj.org/article/aa2aa9ca56e34b18a3125bbedffe2761
Publikováno v:
Bulletin of the World Health Organization
Access to safe, effective, good-quality medicines can be compromised by poor pharmaceutical system governance. This system is particularly vulnerable to inefficiencies and to losses from corruption, because it involves a complex mix of actors with di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd2c38ce6175deefa2ef9bdba6b43764
https://doi.org/10.2471/blt.17.206516
https://doi.org/10.2471/blt.17.206516
Autor:
David Henry, M Jayanthi, Anbarasan Mohan, Verica Ivanovska, Kathleen Holloway, Gilles Forte, Solaiappan Manikandan
Publikováno v:
SSRN Electronic Journal.
Background: Poor quality use of medicines (QUM) has adverse outcomes. Governments implement essential medicines (EM) policies with limited information on which policies are most effective. Methods: We analysed data on policy implementation from WHO s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abb05e414d01eb3d55dbbc253600af29
https://doi.org/10.2139/ssrn.3426083
https://doi.org/10.2139/ssrn.3426083